You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Bulk Pharmaceutical API Sources for TRIDIL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for TRIDIL

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Get Started Free 4510 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1L1IBV ⤷  Get Started Free
ChemMol ⤷  Get Started Free 49417224 ⤷  Get Started Free
Chembase.cn ⤷  Get Started Free 608 ⤷  Get Started Free
ChemTik ⤷  Get Started Free CTK1H0320 ⤷  Get Started Free
AN PharmaTech ⤷  Get Started Free AN-24427 ⤷  Get Started Free
SelectLab Chemicals GmbH ⤷  Get Started Free Ex168 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Tridil

Last updated: July 30, 2025

Introduction

Tridil, the brand name for nitroglycerin, remains a cornerstone in managing acute and chronic angina pectoris. As a potent vasodilator, nitroglycerin’s therapeutic efficacy hinges on the quality and reliability of its active pharmaceutical ingredient (API). Ensuring consistent quality, regulatory compliance, and supply chain stability of nitroglycerin API is a priority for pharmaceutical manufacturers, distributors, and healthcare providers globally. This analysis details the leading bulk API sources for Tridil, evaluates their market positioning, regulatory status, and supply considerations, enabling stakeholders to make informed sourcing decisions.

Overview of Nitroglycerin API

Nitroglycerin (chemical formula: C₃H₅N₃O₉) is a nitrate ester synthesized via nitration of glycerol. Its manufacturing involves complex chemical processes that require strict control over reaction conditions, purification, and stabilization due to its explosive nature. The API’s quality profile depends heavily on raw material quality, process control, and impurity management. The API is supplied in various forms—powders, solutions, or stable forms suitable for parenteral or transdermal formulations.

Leading Global API Manufacturers for Tridil

  1. Northstar Medical Technologies

Northstar is a US-based manufacturer recognized for high-quality nitroglycerin API production. They specialize in manufacturing pharmaceuticals with rigorous CGMP compliance, catering to North American markets. Northstar’s API is consistently validated for potency, purity, and stability, making it a preferred supplier for both small and large pharmaceutical firms seeking reliable supply.

  1. Famar Health Care Services

Based in Greece, Famar is a prominent European API manufacturer with extensive experience in nitrates, including nitroglycerin. Their API manufacturing adheres to stringent European regulations (EMA GMP standards), and they serve a broad customer base across Europe and globally. Famar offers competitive pricing and consistent quality, supporting various formulations of Tridil.

  1. Hawkins Pharmaceutical Corporation

Hawkins is an Indian manufacturer with a significant presence in the global nitrate API market. Their nitroglycerin API production complies with USP and other international standards. Hawkins emphasizes scalable production and has supplied bulk APIs for large-scale manufacturing of nitroglycerin-based drugs, including Tridil.

  1. Wuhan Institute of Fine Chemical Co., Ltd.

This Chinese API manufacturer has gained international recognition for nitrates, including nitroglycerin. Their API meets both EU and US standards, with certifications supporting export to regulated markets. Wuhan’s strategic location and manufacturing capacity allow for cost-effective supply, albeit with rigorous quality assurance processes.

  1. Kingdomway Biotech

Another Chinese API producer, Kingdomway specializes in nitrate pharmaceuticals. They have achieved certification under various regulatory agencies and have a history of supplying nitroglycerin API for global markets, including for injectable and transdermal formulations.

Regulatory and Certification Considerations

Reliable sources of nitroglycerin API must maintain compliance with international standards such as:

  • US Pharmacopeia (USP)
  • European Pharmacopoeia (EP)
  • Good Manufacturing Practices (GMP)
  • ISO Certifications for quality management systems

Manufacturers with validated processes and comprehensive quality assurance systems mitigate risks associated with impurities, stability, and batch-to-batch variability, essential for APIs used in cardiac care.

Supply Chain Dynamics and Challenges

The chemical synthesis of nitroglycerin is sensitive and requires strict safety protocols, impacting manufacturing capacity and costs. Supply chain disruptions, geopolitical factors, and raw material availability influence API sourcing decisions. Notably, the explosive nature of the compound necessitates robust handling, transportation, and storage infrastructures, often favoring manufacturers with established safety records and global logistics capabilities.

Emerging Trends and Alternative Sources

While traditional APIs sourced from established manufacturers dominate, emerging trends include:

  • Vertical Integration: Large pharmaceutical firms integrating API manufacturing to secure supply and quality control.
  • Strategic Partnerships: Collaborations between API producers and formulators to ensure supply continuity.
  • Regionalization: Development of regional API production centers to reduce reliance on long supply chains, especially post-pandemic disruptions.

Conclusion

The procurement of nitroglycerin API for Tridil demands scrutiny of manufacturer accreditation, process robustness, regulatory compliance, and logistical reliability. Northstar, Famar, Hawkins, Wuhan Institute, and Kingdomway emerge as leading candidates, each with distinct advantages in quality, cost, and supply flexibility. Pharmaceutical companies and distributors should prioritize API sources that demonstrate consistent quality, regulatory adherence, and resilient supply chains to ensure uninterrupted availability of Tridil.


Key Takeaways

  • Selection of API sources for Tridil must prioritize GMP compliance, regulatory certifications, and process validation.
  • North American, European, and Chinese manufacturers are key players, each offering unique benefits based on location, cost, and regulatory standing.
  • Supply chain resilience, including safety protocols and logistics infrastructure, is critical given nitroglycerin’s hazardous nature.
  • Strategic partnerships and regional API manufacturing are potential pathways to mitigate supply risks.
  • Continuous monitoring of regulatory updates and quality audits enhances procurement stability in the volatile API landscape.

FAQs

1. What are the primary considerations when sourcing nitroglycerin API for Tridil?
Manufacturers should evaluate GMP compliance, regulatory approvals (FDA, EMA), process validation, impurity profiles, production capacity, and logistical reliability to ensure consistent API quality and supply.

2. Are Chinese API manufacturers suitable for sourcing nitroglycerin?
Yes. Several Chinese manufacturers meet international standards (US, EU) and offer cost-effective solutions. Suppliers like Wuhan Institute and Kingdomway are recognized for quality, but due diligence, including audits and certifications, is essential.

3. How does regulatory compliance influence API sourcing decisions?
Regulatory compliance ensures API quality, safety, and efficacy, essential for approval in different markets. Choosing certified APIs reduces regulatory hurdles and recalls, safeguarding the manufacturer’s reputation and market access.

4. What risks are associated with sourcing nitroglycerin API internationally?
Risks include supply disruptions due to geopolitical tensions, transportation logistic challenges, raw material shortages, safety considerations during manufacturing and shipping, and variations in quality control standards.

5. How can companies mitigate supply chain risks for nitroglycerin API?
Developing diversified supplier networks, establishing long-term contracts, conducting regular audits, maintaining safety stock, and collaborating with local regional API producers can enhance supply stability.


Sources

  1. U.S. Pharmacopeia. Nitroglycerin Monograph.
  2. European Pharmacopoeia. Nitroglycerin Specifications.
  3. GMP Guidelines by the WHO. Pharmaceutical Quality Assurance.
  4. Northstar Medical Technologies. API Product Specifications.
  5. Famar Group. API Manufacturing Capabilities.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.